Complex Regional Pain Syndrome Market Segments and Forecast By End-us FMI | Page 5
As CRPS can begin at any age including children , 90 % of CRPS occurs if enough care is not taken by an individual after any serious injury such as fractures , soft tissue injury , limb immobilization , sprains and surgical procedures . National Institutes of Health ( NIH ) is supporting research for CRPS on the brain and CNS by focusing on studying new approaches in treating CRPS .
On the basis of region prevalence , CRPS is segmented into five key regions : North America , Latin America , Europe , Asia Pacific , and Middle East & Africa .
Request for TOC : http :// www . futuremarketinsights . com / toc / rep-gb-1708
As it is one of the rare condition there is limited data available for regional market share for CRPS but there are 50 % chances of multiple sclerosis ( MS ) patients to develop CRPS and currently North America is one of the leading region in terms of market share followed by Europe and Asia pacific .
Some of the key market players of the complex regional pain syndrome market include Mallinckrodt Pharmaceutical , GlaxoSmithKline plc ., Mylan N . V ., Teva Pharmaceutical Industries Ltd ., AbbVie , ACTAVIS , Zydus Pharmaceuticals , Inc ., Sandoz , and Janssen Global Services , LLC ..
Report Description
As CRPS can begin at any age including children , 90 % of CRPS occurs if enough care is not taken by an individual after any serious injury such as fractures , soft tissue injury , limb immobilization , sprains and surgical procedures . National Institutes of Health ( NIH ) is supporting research for CRPS on the brain and CNS by focusing on studying new approaches in treating CRPS .
On the basis of region prevalence , CRPS is segmented into five key regions : North America , Latin America , Europe , Asia Pacific , and Middle East & Africa .
Request for TOC : http :// www . futuremarketinsights . com / toc / rep-gb-1708
As it is one of the rare condition there is limited data available for regional market share for CRPS but there are 50 % chances of multiple sclerosis ( MS ) patients to develop CRPS and currently North America is one of the leading region in terms of market share followed by Europe and Asia pacific .
Some of the key market players of the complex regional pain syndrome market include Mallinckrodt Pharmaceutical , GlaxoSmithKline plc ., Mylan N . V ., Teva Pharmaceutical Industries Ltd ., AbbVie , ACTAVIS , Zydus Pharmaceuticals , Inc ., Sandoz , and Janssen Global Services , LLC ..